Influenza Viruses

  • Fred M. Davenport

Abstract

Epidemic influenza remains the last great uncontrolled plague of mankind. Epidemics of influenza A and influenza B recur with monotonous frequency, and each quietly but relentlessly exacts its death toll. Periodically worldwide pandemics levy larger and more conspicuous liens. Vaccines developed for control of influenza have been shown to be highly effective when applied to selected segments of the general population, but to date they have not been employed on a scale large enough to determine whether their use can interrupt nationwide epidemic spread. The primary strategy for partial containment of influenza has been to concentrate effort on prevention of lethal outcomes by vaccination of persons known to be at high risk. However, intensified efforts in education of the medical profession and the public concerning the importance of immunization against influenza and development of mechanisms for overcoming chronic vaccine shortages and mal-distributions will be required in order to achieve a significant degree of control.(64)

Keywords

Attenuation Pneumonia Tuberculosis Diarrhea Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson, T., Grist, N. R., Landsman, J. B., Laidlaw, S. I. A., and Weir, I. B. L., An epidemic of influenza due to virus B, Br. Med. J. 1: 7–11 (1953).PubMedGoogle Scholar
  2. 2.
    Andrewes, C. H., Laidlaw, P. P., and Smith, W., Influenza: Observations on the antibody content of human sera, Br. J. Exp. Pathol. 16: 566–582 (1935).Google Scholar
  3. 3.
    Assaad, F., Cockburn, W. C., and Sundaresan, T. K., Use of excess mortality from respiratory diseases in the study of influenza. Bull. WHO 49: 219–233 (1973).PubMedGoogle Scholar
  4. 4.
    Baron, S., and Isaacs, A., Absence of interferon in lungs from fatal cases of pneumonia, Br. Med. J. 1: 18–20 (1962).PubMedGoogle Scholar
  5. 5.
    Beare, A. S., Methods of obtaining viruses suitable for live influenza vaccines and their potential efficacy in man, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 21–29, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  6. 6.
    Burnet, F. M., Influenza virus isolated from an Australian epidemic, Med. J. Aust. 2: 651–653 (1935).Google Scholar
  7. 7.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 88, p. 8, January 1973.Google Scholar
  8. 8.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 89, p. 22, February 1974.Google Scholar
  9. 9.
    Center for Disease Control, Morbidity and Mortality Weekly Report 23, No. 18, p. 167, May 4, 1974.Google Scholar
  10. 10.
    Chang, W. K., National influenza experience in Hong Kong, Bull. WHO 41: 349–351 (1968).Google Scholar
  11. 11.
    Chu, C. M.. The action of normal mouse serum on influenza virus, J. Gen. Microbiol. 5: 739–757 (1951).PubMedGoogle Scholar
  12. 12.
    Collins, S. D., Influenza in the United States 1887–1956 Public Health Monograph No. 48, Government Printing Office, Washington, D.C., 1957.Google Scholar
  13. 13.
    Communicable Disease Center, Influenza—Respiratory Disease Surveillance Report No. 82, p. 6, June 30, 1966.Google Scholar
  14. 14.
    Communicable Disease Center, Influenza Surveillance, Report No. 72, p. 10, May 31, 1962.Google Scholar
  15. 15.
    Communicable Disease Center, Influenza Surveillance, Report No. 72, Supplement, May 31, 1962.Google Scholar
  16. 16.
    Couch, R. B., Douglas, R. G., Rossen, R., and Kasel, J. A., Role of secretory antibody in influenza, in: The Secretory Immunologic System (D. H. Dayton, JR., P. A. Small, Jr., R. M. Chanock, H. E. Kaufman, and T. B. Tomasi, eds.), pp. 93–112, National Institute of Child Health and Development, Government Printing Office, Washington, D.C., 1969.Google Scholar
  17. 17.
    Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L., and Kilbourne, E. D., Induction of partial immunity to influenza by a neuraminidase-specific vaccine, J. Infect. Dis. 129: 411–420 (1974).PubMedGoogle Scholar
  18. 18.
    Czekalowski, J. W., and Prasad, A. K., Studies on influenza vims. I. Antigenic variation in influenza virus type C, Arch. Gesamte Virusforsch. 42: 215–227 (1973).PubMedGoogle Scholar
  19. 19.
    Dauer, C. C., and Serfling, R. E., Mortality from influenza 1957–1958 and 1959–1960, International Conference on Asian Influenza, Am. Rev. Resp. Dis. 83(2): Part 2, 15–26 (1961).Google Scholar
  20. 20.
    Davenport, F. M., Recent advances in prevention of influenza by vaccination. Mod. Med. 26: 115–122 (1958).Google Scholar
  21. 21.
    Davenport, F. M., Pathogenesis of influenza. Conference on Airborne Infection, Bacteriol. Rev. 25: 294–300 (1961).PubMedGoogle Scholar
  22. 22.
    Davenport, F. M., Killed influenza virus vaccines: Present status, suggested use, desirable developments, in: Proceedings: International Conference on the Application of Vaccines Against Viral, Rickettsial and Bacterial Diseases of Man, Pan American Health Organization—World Health Organization, Washington, D.C., December 14-18, 1970, pp. 85-95, PAHO Scientific Publication No. 226, 1971.Google Scholar
  23. 23.
    Davenport, F. M., Control of influenza. Symposium on Influenza, Med. J. Aust. Spec. Suppl. 1: 33–38 (1973).Google Scholar
  24. 24.
    Davenport, F. M., and Hennessy, A. V., The clinical epidemiology of Asian influenza, Ann. Intern. Med. 49: 493–501 (1958).PubMedGoogle Scholar
  25. 25.
    Davenport, F. M., Hennessy, A. V., Brandon, F. M., Webster, R. G., Barrett, C. D., and Lease, G. O., Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins, J. Lab. Clin. Med. 63: 5–13 (1964).PubMedGoogle Scholar
  26. 26.
    Davenport, F. M., Hennessy, A. V., Drescher, J., Mulder, J., and Francis, T., Jr., Further observations on the relevance of serologic recapitulations of human infection with influenza virus, J. Exp. Med. 120:1087–1097 (1964),Google Scholar
  27. 27.
    Davenport, F. M., Hennessy, A. V., and Francis, T., JR., Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus, J. Exp. Med. 98: 641–656 (1953).PubMedGoogle Scholar
  28. 28.
    Davenport, F. M., Hennessy, A. V., and Minuse, E., Further observations on the significance of Al Equine-2/63 antibodies in man, J. Exp. Med. 126: 1049–1061 (1967).PubMedGoogle Scholar
  29. 29.
    Davenport, F. M., Hennessy, A. V., Minuse, E., Maassab, H. F., Anderson, G. R., Mitchell, J. R., Heffelfinger, J. C., and Barrett, C. D., Jr., Pilot studies on mono and bivalent live attenuated influenza virus vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 105–113, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  30. 30.
    Davenport, F. M., and Minuse, E., Influenza viruses, in: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd ed. (E. H. Lennette and N. J. schmidt, eds.), pp. 455–469, American Public Health Association, Inc., New York, 1964.Google Scholar
  31. 31.
    Davenport, F. M., Minuse, E., Hennessy, A. V., and Francis, T., Jr., Interpretations of influenza antibody patterns of man. Bull. WHO 41: 453–460 (1969).PubMedGoogle Scholar
  32. 32.
    Davenport, F. M., and Monto, A. S., Practical considerations in the diagnosis of myxovirus infections, Am. J. Clin. Pathol. 57: 777–782 (1972).PubMedGoogle Scholar
  33. 33.
    Davis, D. J., Problems of allocation and distribution of influenza vaccines. International Conference on Asian Influenza, Am. Rev. Resp. Dis. 83(2): Part 2, 168–170 (1961).Google Scholar
  34. 34.
    Dingle, J. H., Badger, G. F., and Jordon, W. S., Jr., Illness in the Home, p. 174, The Press of Western Reserve University, Cleveland, 1964.Google Scholar
  35. 35.
    Dowdle, W. R., Coleman, M. T., Hall, E. C., and Knez, V.. Properties of the Hong Kong influenza virus. 2. Antigenic relationship of the Hong Kong virus hemagglutinin to that of other human influenza A viruses. Bull. WHO 41: 419–424 (1969).PubMedGoogle Scholar
  36. 36.
    Edwards, E. A., Mammen, R. E., Rosenbaum, M. J., Peckinpaugh, R. O., Mitchell, J. R., Maassab, H. F., Minuse, E., Hennessy, A. V., and Davenport, F. M., Live influenza vaccine studies in human volunteers, in: International Symposium on Influenza Vaccines for Men and Horses, London, 1972 (F. T. Perkins, London, and R. H. Regamey, Geneva, eds.), pp. 289–294, 39th Symp., Ser. Immunobiol. Standard., Vol. 20, 1973.Google Scholar
  37. 37.
    Eickhoff, T. C., Sherman, I. L., and Serfling, R. E., Observations on excess mortality associated with epidemic influenza, J. Am. Med. Assoc. 176: 104–110 (1961).Google Scholar
  38. 38.
    Fazekas de St. Groth, S., and Donnelley, M., The protective value of active immunization, Aust. J. Exp. Biol. Med. Sci. 28: 61–75 (1950).Google Scholar
  39. 39.
    Fox, J. P., and Kilbourne, E. D., Epidemiology of influenza. Summary of Influenza Workshop IV, J. Infect. Dis. 128: 361–386 (1973).Google Scholar
  40. 40.
    Francis, T., Jr., Transmission of influenza by a filterable virus. Science 80: 457–459 (1934).PubMedGoogle Scholar
  41. 41.
    Francis, T., Jr., Epidemiological studies in influenza, Am. J. Public Health 27: 211–225 (1937).Google Scholar
  42. 42.
    Francis, T., Jr., A new type of virus from epidemic influenza. Science 92: 405–408 (1940).PubMedGoogle Scholar
  43. 43.
    Francis, T., JR., Factors conditioning resistance to epidemic influenza, Harvey Lect. Ser. 37: 69–99 (1941).Google Scholar
  44. 44.
    Francis, T., Jr., Influenza: The newe acquayantance, Ann. Intern. Med. 39: 203–221 (1953).PubMedGoogle Scholar
  45. 45.
    Francis, T., Jr., On the doctrine of original anti-genic sin, Proc. Am. Phil. Soc. 104: 572–578 (1960).Google Scholar
  46. 46.
    Francis, T., Jr., and Maassab, H. F., in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, Jr., and I. Tamm, eds.), pp. 689–740, Lippincott, Philadelphia, 1965.Google Scholar
  47. 47.
    Francis, T., Jr., Quilligan, J. J., Jr., and Minuse, E. Identification of another epidemic respiratory disease. Science 112: 495–497 (1950).PubMedGoogle Scholar
  48. 48.
    Francis, T., Jr., Salk, J. E., Pearson, H. E., and Brown, P. N., Protective effect of vaccination against induced influenza A, J. Clin. Invest. 24: 536–546 (1945).PubMedGoogle Scholar
  49. 49.
    Francis, T., Jr., Salk, J. E., and Quilligan, J. J., JR., Experience with vaccination against influenza in the spring of 1947, Am. J. Public Health 37: 1013–1016 (1947).Google Scholar
  50. 50.
    Fry, J., 1961 influenza pattern, Br. Med. J. 1: 745–746 (1961).Google Scholar
  51. 51.
    Fukumi, H., Summary report on the Asian influenza epidemic in Japan 1957, Bull. WHO 20: 187–198 (1959).PubMedGoogle Scholar
  52. 52.
    Fukumi, H., Interpretation of influenza antibody patterns in man. Bull. WHO 41: 469–473 (1969).PubMedGoogle Scholar
  53. 53.
    Hall, C. E., Cooney, M. K., and Fox, J. P., The Seattle virus watch. Am. J. Epidemiol. 98: 365–380 (1973).PubMedGoogle Scholar
  54. 54.
    Hennessy, A. V., Davenport, F. M., Horton, R. J. M., Napier, J. A., and Francis, T., Jr., Asian influenza: Occurrence and recurrence, a community and family study. Mil. Med. 129: 38–50 (1964).Google Scholar
  55. 55.
    Hirsch, A., Handbook of Geographical and Historical Pathology, Vol. 1, pp. 7–17, translated from the second German edition by Charles Creighton, New Sydenham Society, London, 1883.Google Scholar
  56. 56.
    Hirst, G. K., The relationship of the receptors of a new strain of virus to those of the mumps-NDV- influenza group, J. Exp. Med. 91: 177–184 (1950).PubMedGoogle Scholar
  57. 57.
    Hobson, D., Beare, A. S., and Gardner, A. W., Haemagglutination-inhibiting serum antibody titres as an index of the response of volunteers to intranasal infection with live attenuated strains of influenza vims, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 73–84, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  58. 58.
    Isaacs, A., and Hitchcock, G., Role of interferon in recovery from virus infections. Lancet 2: 69–71 (1960).PubMedGoogle Scholar
  59. 59.
    Jackson, G. G., Stanley, E. D., and Muldoon, R. L., Prospects for the control of viral diseases with chemical substances, PAHO Sci. Pub. 226: 588–601 (1970).Google Scholar
  60. 60.
    Jensen, K. E., and Francis, T., Jr., The antigenic composition of influenza virus measured by anti-body-absorption, J. Exp. Med. 98: 619–639 (1953).PubMedGoogle Scholar
  61. 61.
    Jordon, W. S., Jr., Denny, F. W., Jr., Badger, G. F., Curtin, C., Dingle, J. H., Oseasohn, R., and Stevens, D. A., A study of illness in a group of Cleveland families. XVII. Occurrence of Asian influenza, Am. J. Hyg. 68: 190–212 (1958).Google Scholar
  62. 62.
    Kasel, J. A., Horne, E. B., Fulk, R. V., Togo, Y., Huber, M., and Hornick, R. B., Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine, J. Immunol 102: 555–562 (1969).PubMedGoogle Scholar
  63. 63.
    Kendal, A. P., A new receptor destroying enzyme in influenza C, in: Symposium on Neuraminidase, Behring Institute Mitteilungen, pp. 18–34, Vol. 55, Marburg, 1974.Google Scholar
  64. 64.
    Kilbourne, E. D., Chanock, R. M., Choppin, P. W., Davenport, F. M., Fox, J. P., Gregg, M. B., Jackson, G. G., and Parkman, P. D., Influenza vaccines—Summary of Influenza Workshop V, J. Infect. Dis. 129: 750–771 (1974).Google Scholar
  65. 65.
    Kilbourne, E. D., Choppin, P. W., Schulze, I. T., Scholtissek, C., and Bucher, D. L., Summary of Workshop I, J. Infect. Dis. 125: 447–455 (1972).Google Scholar
  66. 66.
    Laidlaw, P. P.. Epidemic influenza: A virus disease, Lancet 1: 1118–124 (1935).Google Scholar
  67. 67.
    Langmuir, A. D., Epidemiology of Asian influenza. Am. Rev. Resp. Dis. 83(2): Part 2, 2–9 (1961).Google Scholar
  68. 68.
    Langmuir, A. D., Henderson, D. A., and Serfling, R. E., The epidemiological basis for control of influenza. Am. J. Public Health 54: 563–571 (1964).Google Scholar
  69. 69.
    Langmuir, A. D., and Housworth, J., A critical evaluation of influenza surveillance. Bull. WHO 41: 393–398 (1969).PubMedGoogle Scholar
  70. 70.
    Mackenzie, J. S., The use of temperature-sensitive mutants in live virus vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 35–41, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  71. 71.
    Magill, T. P., and Francis, T., Jr., Antigenic differences in strains of human influenza virus, Proc. Soc. Exp. Biol. Med. 35: 463–466 (1936).Google Scholar
  72. 72.
    Marine, W. M., and Workman, W. M., Hong Kong influenza immunologic recapitulation. Am. J. Epidemiol. 901: 406–415 (1969).Google Scholar
  73. 73.
    Marine, W. M., Workman, W. M., and Webster, R. G., Immunological interrelationships of Hong Kong, Asian and Equi-2 influenza viruses in man. Bull. WHO 41: 475–s482 (1969).PubMedGoogle Scholar
  74. 74.
    Masurel, N., Relation between Hong Kong virus and former Ag isolates and the A/Equi/2 virus in human sera collected before 1957, Lancet 1: 907–910 (1969).PubMedGoogle Scholar
  75. 75.
    Masurel, N., Serological characteristics of a “new” serotype of influenza A virus: The Hong Kong strain. Bull. WHO 41: 461–468 (1969).PubMedGoogle Scholar
  76. 76.
    Masurel, N., and Marine, W. M., Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man. Am. J. Epidemiol. 97: 44–49 (1973).PubMedGoogle Scholar
  77. 77.
    Masurel, N., and Mulder, J., Studies on the content of haemagglutinin-inhibiting antibody for swine influenza virus, A. Verk. Inst. Prev. Geneesk. 52: 1 (1962).Google Scholar
  78. 78.
    McLean, R. L., General discussion. International Conference on Asian Influenza, Am. Rev. Resp. Dis. 83(2): Part 2, 36–38 (1961).Google Scholar
  79. 79.
    Melnick, J. L., Classification and nomenclature of animal viruses 1971, Prog. Med. Virol. 13: 462–484 (1971).PubMedGoogle Scholar
  80. 80.
    Meyer, H. M., Jr., Hilleman, M. R., Miesse, M. L., Crawford, I. P., and Bankhead, A. S., New anti-genic variant in Far East influenza epidemic, 1957, Proc. Soc. Exp. Biol. Med. 95: 609–616 (1957).PubMedGoogle Scholar
  81. 81.
    Mestuse, E., Willis, P. W., III, and Davenport, F. M., An attempt to demonstrate viremia in cases of Asian influenza, J. Lab. Clin. Med. 59: 1016–1019 (1962).Google Scholar
  82. 82.
    Monto, A. S., Davenport, F. M., Napier, J. A., and Francis, T., JR., Effect of vaccination of a school-age population upon the course of an A2 Hong Kong influenza epidemic. Bull. WHO 41: 537–542 (1969).PubMedGoogle Scholar
  83. 83.
    Mulder, J., and Hers, J. F. P., Influenza, pp. 9–204, Wolters-Noordhoff, Groningen, the Netherlands, 1972.Google Scholar
  84. 84.
    Mulder, J., and Masurel, N., Pre-epidemic anti-body against the 1957 strain of Asiatic influenza in the serum of older persons living in the Netherlands, Lancet 1: 810–814 (1958).PubMedGoogle Scholar
  85. 85.
    Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., and Chanock, R. M., Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man, J. Infect. Dis. 126: 170–178 (1972).PubMedGoogle Scholar
  86. 86.
    Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., Kasel, J., and Chanock, R. M., Attenuation of ts recombinants for man. III. Further characterization of ts-1 (E) influenza A recombinant (H3N2) virus in man, J. Infect. Dis. 128: 479–487 (1973).PubMedGoogle Scholar
  87. 87.
    Murray, R., Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1968–69, Bull. WHO 41: 495–496 (1969).PubMedGoogle Scholar
  88. 88.
    Oseasohn, R., Adelson, L., and Kaji, M., Clinico- pathologic study of thirty-three fatal cases of Asian influenza, N. Engl. J. Med. 260: 509–518 (1959).PubMedGoogle Scholar
  89. 89.
    Pickles, W. N., Burnet, F. M., and McArthur, N., Epidemic respiratory infection in a rural population with special reference to the influenza A epidemics of 1933, 1936-7 and 1943-4, J. Hyg. 45: 469–479 (1947).Google Scholar
  90. 90.
    Plummer, N., Essential industry and its role in an influenza epidemic. International Conference on Asian Influenza, Am. Rev. Resp. Dis. 83(2): Part 2, 211–214 (1961).PubMedGoogle Scholar
  91. 90a.
    Pons, M. W., A reexamination of influenza single- and double-stranded RNA’s by gel electrophoresis. Virology 69: 789–792 (1976).PubMedGoogle Scholar
  92. 91.
    Rosenstock, I. M., Public acceptance of influenza vaccination programs. International Conference on Asian Influenza, Am. Rev. Resp. Dis. 83(2): Part 2, 171–174 (1961).Google Scholar
  93. 92.
    Salk, J. E., Menke, W. J., and Francis, T., JR., A clinical, epidemiological and immunological evalua¬tion of vaccination against epidemic influenza. Am. J. Public Health 42: 57–93 (1945).Google Scholar
  94. 93.
    Salk, J. E., Pearson, H. E., Brown, P. N., and Francis. T., JR., Protective effect of vaccination against induced influenza B, J. Clin. Invest. 24: 547–553 (1945).PubMedGoogle Scholar
  95. 94.
    Schild, G. C., Henry-Aymard, M., and Pereira, H. G., A quantitative, single-radial-diffusion test for immunological studies with influenza virus, J. Gen. Virol. 16: 231–236 (1972).PubMedGoogle Scholar
  96. 95.
    Schild, G. C., Henry-Aymard, M., Pereira, M. S., Chakraverty, P., Dowdle, W., Coleman, M., and Chang, W. K., Antigenic variation in current human type A influenza viruses: Antigenic characteristics of the variants and their geographic distribution, Bull. WHO 48: 269–278 (1973).PubMedGoogle Scholar
  97. 96.
    Schild, G. C., Pereira, M. S., Chakraverty, P., Coleman, M. T., Dowdle, W. R., and Chang, W. K., Antigenic variants of influenza B virus, Br. Med. J. 4: 127–131 (1973).PubMedGoogle Scholar
  98. 97.
    Schild, G. C., and Stuart-Harris, C. H., Serologic epidemiological studies with influenza A viruses, J. Hyg. 63: 479–490 (1965).Google Scholar
  99. 98.
    Schulze, I. T., The structure of influenza virus: A model based on the morphology and composition of subviral particles. Virology 47: 181–196 (1972).PubMedGoogle Scholar
  100. 99.
    Serfling, R. E., Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep. (USA) 78: 494–506 (1963).Google Scholar
  101. 100.
    Sharrar, R. G., National influenza experience in the U.S.A.; 1968–69, Bull. WHO 41: 361–366 (1969).PubMedGoogle Scholar
  102. 101.
    Shope, R. E., Swine influenza. III. Filtration experiments and etiology, J. Exp. Med. 54: 373–385 (1931).PubMedGoogle Scholar
  103. 102.
    Shope, R. E., The incidence of neutralizing antibodies for swine influenza virus on the sera of human beings of different ages, J. Exp. Med. 63: 669–684 (1936).PubMedGoogle Scholar
  104. 103.
    Sigel, M. M., Kitts, A. W., Light, A. B., and Henle, W., The recurrence of influenza A prime in a boarding school after 2 years, J. Immunol. 64: 33–38 (1950).PubMedGoogle Scholar
  105. 104.
    Slepushkin, A. N., Schild, G. C., Beare, A. S., Chinn, S., Freestone, D., Hall, T., and Tyrrell, D. A. J., Antineuraminidase antibody and resist-ance to vaccination with live influenza A2 Hong Kong vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 85–92, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  106. 105.
    Smith, W., Andrewes, C. H., and Laidlaw, P. P., A virus obtained from influenza patients. Lancet 2: 66–68 (1933).Google Scholar
  107. 106.
    Solov’ev, V. D., The results of controlled observations on the prophylaxis of influenza with inter-feron, Bull. WHO 41: 683–688 (1969).PubMedGoogle Scholar
  108. 107.
    Stanley, E. D., and Jackson, G. G., Viremia in Asian influenza. Trans. Assoc. Am. Phys. 79: 376–387 (1966).PubMedGoogle Scholar
  109. 108.
    Stuart-Harris, C. H., Influenza and Other Virus Infections of the Respiratory Tract, pp. 8-21, Williams and Wilkins, Baltimore, 1965.Google Scholar
  110. 109.
    Stuart-Harris, Sir Charles H., Pandemic influenza: An unresolved problem in prevention, J. Infect. Dis. 122: 108–115 (1970).Google Scholar
  111. 110.
    Stuart-Harris, Sir Charles H., Control of influenza, lack of knowledge versus lack of application of knowledge. Arch. Environ. Health 21: 276–284 (1970).Google Scholar
  112. 111.
    Taylor, R. M., A further note on 1233 (“influenza C”) vims. Arch. Gesamte Virusforsch. 4: 485–500 (1951).PubMedGoogle Scholar
  113. 112.
    Thomson, D., and Thomson, R., Influenza, Ann. Pickett-Thomson Res. Lab. 9: 4 (1933).Google Scholar
  114. 113.
    Tyrrell, D. A. J., and Beare, A. S., Live influenza virus vaccines: An interim report, PAHO Sci. Pub. 226: 96–100 (1971).Google Scholar
  115. 114.
    Waldman, R. H., Bond, J. O., Levitt, L. P., Hartwig, E. C., Prather, E. C., Baratta, R. L., Neill, J. S., and Small, P. A., Jr., An evaluation of influenza immunization: Influence of route of administration and vaccine strain. Bull. WHO 41: 543–548 (1969).PubMedGoogle Scholar
  116. 115.
    Waldman, R. H., Small, P. A., Jr., and Rowe, D. S., Utilization of the secretory immunologic system for protection against disease, in: The Secretory Immunologic System (D. H. Dayton, Jr., P. A. Small, Jr., R. M. Chanock, H. E. Kaufman, and T. B. Tomasi, eds.), pp. 129–147, National Institute of Child Health and Development, Government Printing Office, Washington, D.C., 1969.Google Scholar
  117. 116.
    Widelock, D., Klein, S., Peizer, L. R., and Simonovic, O., A laboratory analysis of 1957-1958 influenza outbreak in New York City. II. A seroepidemiological study, Am. J. Public Health 49: 847–856 (1959).Google Scholar
  118. 117.
    Zakstelskaya, L. Y., Recovery of the virus from the urine of patients with epidemic influenza, Gupp: OKUDR Trans. Ob’jed. Sess. Inst. AMN SSSR, Moscow, 71 (1953).Google Scholar
  119. 118.
    Zakstelskaja, L. Y., Evstigneeva, N. A., Isachenko, V. A., Shenderovitch, S. P., and Efimo VA, V. A., Influenza in the USSR: New antigenic variant A2/Hong Kong/1/68 and its possible precursors. Am. J. Epidemiol 90: 400–405 (1969).PubMedGoogle Scholar
  120. 119.
    Zhdanov, V. M., Solovev, V. D., and Epshtein, F. G., The Study of Influenza: Epidemiology, pp. 648–732, Russian Scientific Translation Program, Division of General Medical Sciences, National Institutes of Health, Bethesda, Md., 1960.Google Scholar

Suggested Reading

  1. Fox, J. P., and Kilbourne, E. D., Epidemiology of influenza. Summary of Influenza Workshop IV, J. Infect. Dis. 128: 361–386 (1973).Google Scholar
  2. Francis, T., Jr., and Maassab, H. F., in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, Jr., and I. Tamm, eds.), pp. 689–740, Lippincott, Philadelphia, 1965.Google Scholar
  3. Hoyle, L., The Influenza Viruses, Springer-Verlag, New York, 1968.Google Scholar
  4. Kilbourne, E. D., The Influenza Viruses and Influenza, Academic Press, New York, 1975.Google Scholar
  5. Stuart-Harris, C. H., Influenza and Other Virus Infections of the Respiratory Tract, Williams and Wilkins, Baltimore, 1965.Google Scholar

Copyright information

© Plenum Publishing Corporation 1976

Authors and Affiliations

  • Fred M. Davenport
    • 1
  1. 1.Department of Epidemiology, School of Public HealthThe University of MichiganAnn ArborUSA

Personalised recommendations